JOSEPH HARRISON: Open Payments
NPI 1104842624 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,984 in 67 payments from 13 companies in 2025. Trend: 2023 $8,975 · 2024 $8,610 · 2025 $14,984
Consulting: $8,625Speaker / faculty: $3,220Food & beverage: $1,685Travel & lodging: $1,454
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 38 | $14,378 |
| Vanda Pharmaceuticals Inc. | 8 | $170 |
| Alkermes, Inc. | 3 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Lundbeck LLC | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $40 |
| Corium, LLC | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: COBENFY, OPDIVO, ARISTADA, FANAPT, HETLIOZ, REXULTI, TRINTELLIX, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
